LeonaBio
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18706 North Creek Pkwy Ste 104, Bothell,...Website
www.leonabio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About LeonaBio
LeonaBio, Inc. is a biotechnology company dedicated to the discovery and development of novel therapeutics, including small-molecule drug candidates for treatment-resistant metastatic breast cancer, amyotrophic lateral sclerosis (ALS), and other serious conditions. It was previously known as Athira Pharma, Inc. and recently rebranded to LeonaBio to reflect its evolving clinical pipeline and strategic focus.Explore more
Popular SearchesLeonaBio IncSIC Code 28,283NAICS Code 32,325Show moreLeonaBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LeonaBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once LeonaBio has new funding data
Check out if LeonaBio is spiking on competitors!
Click to see if LeonaBio had a recent Job posting/layoffs
LeonaBio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when LeonaBio launches new products
Earning: See what the market has to say on LeonaBio recently announced quarterly report
Check if LeonaBio has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at LeonaBio
Recommended Actions
Reach out to Masked Content who joined LeonaBio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
LeonaBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LeonaBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LeonaBio.
LeonaBio Tech Stack
A closer look at the technologies used by LeonaBio
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
LeonaBio News & Media
Seattle-area biotech led by ex-Athira CEO Leen Kawas raises $35M for hepatitis D drug
EIT Pharma CEO Leen Kawas (EIT Pharma Photo) A Kirkland, Wash.-based biotech company led by former Athira Pharma CEO Leen Kawas has raised $35 million inLeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances
LeonaBio, Inc. (NASDAQ:LONA) reported a smaller-than-expected second-quarter loss on Monday as the clinical-stage biopharmaceutical company continued to advance its pivotal Phase 3 ELAINE-3 study of lasofoxifene.LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update
On Track to Complete Enrollment of Phase 3 ELAINE-3 Clinical Trial of Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer in 4Q 2026 with Topline Data Expected in 2H 2027LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
On Track to Complete Enrollment of the Phase 3 ELAINE-3 clinical trial in 4Q 2026 with Topline Data Expected in 2H 2027 On Track to Complete Enrollment of the Phase 3 ELAINE-3 clinical trial in 4Q 2026 with Topline Data Expected in 2H 2027
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LeonaBio
Sign Up For FreeTo access detailed company insights
LeonaBio, Inc. is a biotechnology company dedicated to the discovery and development of novel therapeutics, including small-molecule drug candidates for treatment-resistant metastatic breast cancer, amyotrophic lateral sclerosis (ALS), and other serious conditions. It was previously known as Athira Pharma, Inc. and recently rebranded to LeonaBio to... Read More
